Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Cell Communication and Signaling : CCS|May 16, 2015
Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell linesJoseph Cursons, Karl-Johan Leuchowius, Mark Waltham, et al.
The Pediatric Infectious Disease Journal|May 12, 2023
Clinical Presentation and Outcome of Acute Respiratory Illnesses in South African Children During the COVID-19 PandemicAndrew Redfern, Marieke M van der Zalm, Juanita Lishman, et al.
Clinical and Translational Science|November 1, 2021
Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)Timothy D Owens, Patrick F Smith, Andrew Redfern, et al.
Asia-Pacific Journal of Clinical Oncology|December 15, 2021
Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and IndiaSherene Loi, Christos S Karapetis, Nicole McCarthy, et al.
Clinical and Vaccine Immunology : CVI|December 26, 2014
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trialNina Wressnigg, Maikel V W van der Velden, Daniel Portsmouth, et al.
African Journal of Emergency Medicine : Revue Africaine De La Medecine D'Urgence|May 2, 2022
SARS-CoV-2 in children and their accompanying caregivers: Implications for testing strategies in resource limited hospitalsLiezl Smit, Andrew Redfern, Sadia Murray, et al.
Clinical Pharmacology and Therapeutics|September 2, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of Osivelotor for Sickle Cell Disease: First-in-Human Studies in Healthy Participants and PatientsEleanor A Lisbon, R Clark Brown, Andrew Redfern, et al.
EMBO Molecular Medicine|March 27, 2025
Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunityBo He, Kira H Wood, Zhi-Jie Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 22, 2023
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast CancerCharlene Waryah, Joseph Cursons, Momeneh Foroutan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2020
Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2-Related Illness in Children: Hospital Experience in Cape Town, South AfricaMarieke M van der Zalm, Juanita Lishman, Lilly M Verhagen, et al.
Pageof 8